Testing effectiveness (Phase 2)Ended earlyNCT04421378
What this trial is testing
Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Who this might be right for
Glioblastoma Multiforme
Karyopharm Therapeutics Inc 74